Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...
The Independent on MSN5d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patientsThe study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...
Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...
Bladder cancer patients given an immunotherapy drug ... Patients were given either standard chemotherapy (cisplatin and gemcitabine) and surgery (530 people), or chemotherapy plus durvalumab ...
A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...
BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback